Form 4: Tonix Pharmaceuticals Director Acquires Stock Options

Richard H. Bagger, a director of Tonix Pharmaceuticals, acquired stock options for 104,621 shares on May 23, 2024, at an exercise price of $0.1745.

Summary

• Richard H. Bagger, a director at Tonix Pharmaceuticals Holding Corp., filed a Form 4 on May 24, 2024.
• The filing reports a transaction that occurred on May 23, 2024, where Bagger acquired stock options for 104,621 shares.
• The exercise price of these options is $0.1745 per share.
• The options were granted under the company's Amended and Restated 2020 Stock Incentive Plan.
• The options vest on the earlier of the one-year anniversary of the grant date or the Issuer's 2025 Annual Meeting of Stockholders and expire on May 23, 2034.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard regulatory filing related to stock option grants. The director's acquisition could be seen as a positive signal, but it's not a major event.

Positives

• The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Stakeholder Impact

• The acquisition of stock options by a director may have a minor positive impact on shareholder sentiment.

Key Dates